Day: December 6, 2022

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing The Series C extension round will accelerate clinical development, manufacturing scale-up and pre-commercialization activities of Pulmocide’s lead product candidate, opelconazole Paris, France, December 6th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to healthcare and biopharma, announced today its participation in a $52 million Series C extension financing round in portfolio company […]

Jeito Capital strengthens its support in Pulmocide with participation in $52 million financing The Series C extension round will accelerate clinical development, manufacturing scale-up and pre-commercialization activities of Pulmocide’s lead product candidate, opelconazole Paris, France, December 6th 2022 – Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to healthcare and biopharma, announced today its participation in a $52 million Series C extension financing round in portfolio company […]

MONTREAL, Dec. 06, 2022 (GLOBE NEWSWIRE) — The Passport Index has published its latest update today, showing that global mobility is rising, despite the eruption of conflict in Europe and growing tensions over borders. Though the world continues to feel the aftershocks of the pandemic, surprisingly, traveling has never been easier, with steady growth in passport […]

MONTREAL, Dec. 06, 2022 (GLOBE NEWSWIRE) — The Passport Index has published its latest update today, showing that global mobility is rising, despite the eruption of conflict in Europe and growing tensions over borders. Though the world continues to feel the aftershocks of the pandemic, surprisingly, traveling has never been easier, with steady growth in passport […]

Acquisition strengthens capabilities in Benelux region TORONTO and BRUSSELS, Belgium, Dec. 06, 2022 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company, Colliers (NASDAQ and TSX: CIGI), announced today that it has acquired a majority interest in BelSquare SRL (“Belsquare”), a leading Belgian commercial real estate advisor with offices in Brussels and Antwerp. […]

Acquisition strengthens capabilities in Benelux region TORONTO and BRUSSELS, Belgium, Dec. 06, 2022 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company, Colliers (NASDAQ and TSX: CIGI), announced today that it has acquired a majority interest in BelSquare SRL (“Belsquare”), a leading Belgian commercial real estate advisor with offices in Brussels and Antwerp. […]